The role of cytokines and cytokine gene polymorphism in T-cell activation and allograft rejection

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 3, 2000, Pages 412-416

  Bunnapradist, Suphamai ^a   Jordan, S C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Allograft rejection; Cytokine gene polymorphism; Immunosuppression

Indexed keywords

CYTOKINE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLOTRANSPLANTATION; ANIMAL; B LYMPHOCYTE; GENETIC POLYMORPHISM; GENETICS; GRAFT REJECTION; HUMAN; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CYTOKINES; GRAFT REJECTION; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; POLYMORPHISM, GENETIC; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034186102     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sankaran D, Asderakis A, Ashraf S, Roberts I S, Short C D, Dyer P A. et al. Cytokine gene polymorphism predict acute graft rejection following renal transplantation. Kidney Int 1999; 56:281-8.
2. Grant S C, Lamb W R, Brooks N H, Brenchley P E, Hutchinson I V. Serum cytokines in human heart transplantation: Is there a relationship to rejection? Transplantation 1996; 62:480-91.
3. Turner D, Grant S C, Yonan N, Sheldon S, Dyer P A, Sinnott P J, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64:776-9.
4. Reinsmoen N L, Jackson A, Cross F, et al. Unique cytokine genotypes associated with chronic rejection and chronic rejection-free states in heart recipients. Transplantation 1999; 67:S46.
5. Hutchinson I V. The role of transforming growth factor-β in transplant rejection. Transplant Proc 1999; 31:9S-13S.
6. Bonavida B, Wright S, Kashiwa H, et al. Immunoregulation and cytotoxicity by tumor necrosis factor. In: Bonavida B, Gifford G E, Kirchner H, Old L J, editors. Tumor Necrosis Factor/Cachectin and Related Cytokines. Basel: Karger, 1988:53-8.
7. Satoh J, Seino H, Abo T, Tanaka S, Shintani S, Ohta S, et al. Recombinant human tumor necrosis factor-alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989; 84:1345-8.
8. Serreze D V, Leiter E, Defective activation of T-suppressor function in non obese diabetic mice. Potential relation to cytokine deficiencies. J Immunol 1988; 140:3801-7.
9. Jacob C O, McDevitt H O. Tumor necrosis factor alpha in murine autoimmune "lupus" nephritis. Nature 1988; 331:356-8.
10. Saito R, Prehn J, Zuo X, Castracain J, Marcheviski A, Waters P, et al. Tumor necrosis factor participates in the pathogenesis of lung allograft rejection in the rat. Transplantation 1993; 55:967-72.
11. Roberts A B, Sporn M B. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993; 8:1-9.
12. Hooper W C. The role of transforming growth factor-beta in hematopoiesis. A review. Leuk Res 1991; 15:179-84.
13. Matriano J, Streilein J. Induction of immunological tolerance In: Sher L, Makowka L, editors. Intra Abdominal Organ Transplantation 2000. RG Landes Co, 1994:249-80.
14. Lebman D A, Lee F D, Coffman R L. Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol 1990; 144: 952-9.
15. Kulkarni A B, Karlsson S. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993; 143:3-9.
16. Qin L, Chavin K D, Ding Y, Favaro J P, Woodward J E, Lin J, et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplant model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation 1995; 59:809-16.
17. Wolf G, Thaiss F, Stahl R A. Cyclosporine stimulates expression of TGF-β in renal cells. Possible mechanism of CSA anti-proliferative effect. Transplantation 1995; 60:237-41.
18. Border W, Noble N. Targeting TGF-β for treatment of disease. Nat Med 1995; 1:1000.
19. Hadley G A, Bartlett S T, Via C S, Rostapshova E A, Moainie S. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+CTL. J Immunol 1997; 159:3748-56.
20. Powrie F, Menon S, Coffman R L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 11:3043-9.
21. Hsu D H, de Waal Malefyt R, Fiorentino D F, Dang M N, Vieira P, de Vries J, et al. Expression of IL-10 activity by Epstein-Barr virus protein BCRF-1. Science 1990; 250:830-2.
22. Zuo X J, Matsumura Y, Prehn J, Saito R, Marchevesky A, Matloff J, et al. Cytokine gene expression in rejecting and tolerant rat lung allograft models. Transpl Immunol 1995; 3:151-61.
23. de Waal Malefyt R, Abrams J, Bennett B, Figdor C G, de Vries J E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
24. Leeuwenberg J F, Jeunhomme T M, Buurman W A. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1994; 152: 4036-43.
25. Willems F, Marchant A, Delville J P, Gerard C, Delvaux A, Velu T, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24:1007-9.
26. de Waal Malefyt R, Yssel H, Roncarolo M G, Spits H, de Vries J E. Interleukin-10. Curr Opin Immunol 1992; 4:314-20.
27. Briere F, Bridon J M, Chevet D, Souillet G, Bienvenu F, Guret C, et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994; 94:97-104.
28. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.